SCHEMBL6723591

SCHEMBL6723591

O=C(COc1c(I)cc(C(=O)c2cc(I)c(O)c(I)c2)cc1I)OCc1ccccc1

nearest known ligand 0.46

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
THRA P10827 3/20 0.46
THRB P10828 3/20 0.46
ALDH1A1 P00352 2/20 0.43
MAPK1 P28482 2/20 0.43
L3MBTL1 Q9Y468 1/20 0.43
LMNA P02545 3/20 0.42
KDM4E B2RXH2 1/20 0.42
POLB P06746 1/20 0.42
HPGD P15428 2/20 0.41
CDC25B P30305 6/20 0.41
KDM5A P29375 1/20 0.41
SLC6A2 P23975 1/20 0.40
SLC6A3 Q01959 1/20 0.40
KMT2A Q03164 1/20 0.40
TDP1 Q9NUW8 1/20 0.40
NPC1 O15118 1/20 0.39
RAB9A P51151 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6723918 0.95 ALDH1A1 (0.47) THRATHRBALDH1A1MAPK1L3MBTL1
SCHEMBL6721180 0.93 ALDH1A1 (0.43) THRATHRBALDH1A1MAPK1L3MBTL1
SCHEMBL6731605 0.92 ALDH1A1 (0.45) THRATHRBALDH1A1MAPK1L3MBTL1
SCHEMBL6725854 0.85 LMNA (0.42) THRATHRBALDH1A1MAPK1L3MBTL1
SCHEMBL6728507 0.82 MEN1 (0.49) THRATHRBALDH1A1L3MBTL1LMNA
SCHEMBL6720862 0.82 KMT2A (0.45) THRATHRBALDH1A1MAPK1L3MBTL1
SCHEMBL7754025 0.81 FFAR1 (0.37) THRATHRBALDH1A1MAPK1L3MBTL1
SCHEMBL22991665 0.79 CDC25B (0.46) ALDH1A1MAPK1L3MBTL1LMNAKDM4E
SCHEMBL6725180 0.78 THRB (0.55) THRATHRBALDH1A1LMNAKMT2A
SCHEMBL6725779 0.77 KMT2A (0.64) ALDH1A1L3MBTL1LMNAHPGDSLC6A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6677473-B1 TREATMENT, PREVENTION OR AMELIORATION OF ONE OR MORE SYMPTOMS OF THROMBOTIC DISORDERS, UNSTABLE ANGINA OR CANCER CORVAS INTERNATIONAL INC 2004-01-13 US claimed
US-6677473-B1 TREATMENT, PREVENTION OR AMELIORATION OF ONE OR MORE SYMPTOMS OF THROMBOTIC DISORDERS, UNSTABLE ANGINA OR CANCER CORVAS INTERNATIONAL INC 2004-01-13 US disclosed
WO-2003009871-A2 INHIBITORS OF PLASMINOGEN ACTIVATOR INHIBITOR FOR DECREASING BODY MASS GENSET S.A. (FR) 2003-02-06 WO disclosed
WO-2001036351-A2 PLASMINOGEN ACTIVATOR INHIBITOR ANTAGONISTS RELATED APPLICATIONS CORVAS INTERNATIONAL, INC. (US) 2001-05-25 WO disclosed